INKON Life Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 28, 2022 at 07:40 am EDT
Share
INKON Life Technology Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 267.55 million compared to CNY 241.65 million a year ago. Revenue was CNY 267.55 million compared to CNY 241.65 million a year ago. Net income was CNY 24.11 million compared to CNY 18.46 million a year ago. Basic earnings per share from continuing operations was CNY 0.0375 compared to CNY 0.0288 a year ago. Diluted earnings per share from continuing operations was CNY 0.0375 compared to CNY 0.0288 a year ago.
INKON Life Technology Co., Ltd., formerly Starmap medicine & technology Co., Ltd., is a China-based company principally engaged in providing medical services. Its medical services focus on cancer prevention, diagnosis, treatment and rehabilitation. The Company is also engaged in the research and development, manufacture and sales of medical equipment, as well as medical software development. Its medical equipment mainly include MASEP digital radiotherapy equipment, MASEP Gamma Knife and other large medical equipment. The Company distributes its products within domestic market and to overseas markets.
INKON LIFE TECHNOLOGY CO., LTD. 
